DARA BioSciences, Inc. (DARA) stock posted today 20.95% in gains on 6,424,094 shares in trading volume and brought to followers for about 55% in profits since our alert issued on September 13th. Our “gut feeling” and quick observation of DARA’s financials “told” us that a second offering for this biotech penny markets most likely is […]
Home» Posts tagged "DARA BioSciences"
DARA BioSciences (DARA): Granted Exclusive U.S. Commercial Rights to Gelclair®
DARA BioSciences, Inc. (DARA) announced today that company entered into an exclusive agreement with The Helsinn Group of Switzerland for U.S. commercial rights to Gelclair®. DARA plans to launch Gelclair, FDA-cleared product indicated for the treatment of oral mucositis, in the first quarter of 2013. Oral mucositis market is approximately 400,000 patients annually according to […]